Time for some good news, page-249

Sensera has great initiatives outside of NanoDiagnostics and the NanoDX device.
As many have posted, including myself,I believe the company has a strong future in the MEMs space no matter what happens to NanoDX.

I believe the market has virtually walked away from Sensera partaking in the Covid19 testing space, which is reflected in the current SP.

And, my take on the "communication style" from Ralph in relation to Nanodiagnostics is that he had almost given up as well.
I perceived an almost "I'll believe it when I see it" statement in the last quarterly.
This frustration was also evident from companies contracted by NanoDiagnostics on the demand side of the business, which includes the infamous Stewart Mackie from GMAS LTD.

But, I also see no indication from NanoDiagnostics that they have walked away from NanoDX delivering a Covid19 solution. In fact Shara Joshi's recent interview would suggest exactly the opposite.

And over the last week we have started to see a few rays of hope that the NanoDX may yet rise. Many here are sceptical, and rightly so. The video from Turning Point solutions had a operating version of NanoDX ... it doesn't look like a mock-up to my untrained eye. Stewart's LinkedIn post overnight is genuine and enthusiastic, and I'm assuming ( perhaps incorrectly ). than Turning Point Solutions would have given him the green light to start pushing NanoDX in his region to be able to publish this on a public forum.

So what to make of all of this. I have increasing confidence that NanoDX will get to market, I have a 60% chance of success on my SE1 spreadsheet. Timing .... well that's another matter .... but I'm beginning to punt it's sooner rather than later.

Each of us need to make an assessment and invest how we feel comfortable. Certainly speculative, but I'm feeling confident.

Very much IMO.
GLTAH